logo_nosopharm
  • About us
  • Science
  • Pipeline
  • News
  • Contact
  • English
    • Français
    • English
Menu
  • About us
  • Science
  • Pipeline
  • News
  • Contact
  • English
    • Français
    • English
News
Groupe 39

news

Subscribe to our newsfeed

partnering opportunities

Nosopharm is open to synergistic collaborations for the development of its pipeline and the progress of its promising drug discovery programs.

Our goal is to explore, with an industrial partner, the drug discovery potential of Photorhabdus and Xenorhabdus bacteria for human and animal health in any therapeutic indication. Our innovative anti-infective drug discovery platform is based on the exploitation of these two antimicrobial-producing bacteria; Nosopharm is the only biotech company to explore these. Nosopharm is also interested in gaining access to new strains of Photorhabdus and Xenorhabdus or related bacteria, in compliance with the Nagoya Protocol.

To explore partnering opportunities with Nosopharm, please contact us.

Contact us

Nosopharm is an innovative biotechnology company specialized in exploring the microbial biodiversity of the genera Photorhabdus and Xenorhabdus to develop new drugs infectious diseases.

sitemap

  • About us
  • Science
  • Pipeline
  • News
  • Contact
  • English
    • Français
    • English
Menu
  • About us
  • Science
  • Pipeline
  • News
  • Contact
  • English
    • Français
    • English
Linkedin-in Twitter

Careers

Discover our job and internship opportunities

Join us
  • © Nosopharm 2022
  • All rights reserved
  • Legal notice
  • Data policy
Menu
  • © Nosopharm 2022
  • All rights reserved
  • Legal notice
  • Data policy